SARAH MAHIPALA, FNP-C
Nurse Practitioner in WATERLOO, Iowa. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
SARAH MAHIPALA, FNP-C filed 566 Medicare Part D claims in 2023 as a Nurse Practitioner in WATERLOO, Iowa, prescribing 78% generic.
- 566
- Part D claims, 2023
- 78%
- generic prescribing
- $471.82
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
SARAH MAHIPALA, FNP-C's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
566 Top 34% higher than 66% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
What does the federal data show about SARAH MAHIPALA, FNP-C?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Iowa
How Nurse Practitioner compares to other specialties among Iowa providers
Nurse Practitioner share within Iowa
Nurse Practitioner is one of the more visible NUCC categories in Iowa
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Nurse Practitioner (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Nurse Practitioner ABMS/AOA estimate
Est. board-certified rate (Nurse Practitioner) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Nurse Practitioner US NPIs
Specialty board-certified rate — Nurse Practitioner estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
SARAH MAHIPALA, FNP-C appears in the CMS NPPES registry as a Nurse Practitioner provider holding FNP-C credentials at 419 E DONALD ST, WATERLOO, IA, 50703, with a listed phone of (319) 236-1911. NPI 1558085456 was issued on 10/04/2022. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MAHIPALA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 566 prescription claims written by this provider, covering 214 Medicare beneficiaries and totaling roughly $102K in drug spend, split 22% brand-name and 78% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Nurse Practitioner is a high-volume specialty nationwide, with 87,227 enrolled providers across 56 states and an average of 1,084 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1558085456 |
|---|---|
| Specialty | Nurse Practitioner |
| Credentials | FNP-C |
| Gender | Female |
| NPI Issued | 10/04/2022 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm SARAH MAHIPALA, FNP-C's current license status, disciplinary history, and board certifications with the Iowa Board of Medicine in Iowa before relying on this page for a clinical or care decision.
How we sourced this profile
Hospital and facility affiliations
Facilities where SARAH MAHIPALA, FNP-C bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for SARAH MAHIPALA, FNP-C. Source: openpaymentsdata.cms.gov.
Total received
$472
Largest payer
Medtronic, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Typical
22% brand-name claims vs 78% generic, on 566 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 974
- Total Day Supply
- 28,522
- Brand vs Generic
- 22% brand / 78% generic
- Brand Drug Cost
- $91K
- Generic Drug Cost
- $11K
- Antibiotic Claims
- 17
Patient Demographics
- Average Patient Age
- 75.8 years
- Avg HCC Risk Score
- 1.57
- Gender Split
- 49% female / 51% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What SARAH MAHIPALA, FNP-C prescribes most
Top Medicare Part D drugs by claim count, 2023
- Eliquis
Eliquis
76 claims
- Amiodarone Hcl
Amiodarone Hcl
67 claims
- Flecainide Acetate
Flecainide Acetate
51 claims
- Sotalol
Sotalol
51 claims
- Metoprolol Succinate
Metoprolol Succinate
46 claims
- Pravastatin Sodium
Pravastatin Sodium
42 claims
- Xarelto 28
Xarelto
28 claims
- Metoprolol Tartrate 24
Metoprolol Tartrate
24 claims
| Drug | Claims |
|---|---|
| Eliquis Apixaban | 76 |
| Amiodarone Hcl | 67 |
| Flecainide Acetate | 51 |
| Sotalol Sotalol Hcl | 51 |
| Metoprolol Succinate | 46 |
| Pravastatin Sodium | 42 |
| Xarelto Rivaroxaban | 28 |
| Metoprolol Tartrate | 24 |
| Furosemide | 18 |
| Midodrine Hcl | 18 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Nurse Practitioner Overview
How SARAH MAHIPALA, FNP-C fits within the Nurse Practitioner landscape nationally.
SARAH MAHIPALA, FNP-C's 566 claims are below the specialty average of 1,084.
Nearby Nurse Practitioner Providers in Iowa
Other clinicians with the same primary specialty enrolled in Iowa, drawn from the same CMS NPPES roster as MAHIPALA.
Compare Nurse Practitioner nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Iowa
Frequently Asked Questions
What is SARAH MAHIPALA, FNP-C's specialty? ▼
How much does SARAH MAHIPALA, FNP-C prescribe under Medicare Part D? ▼
Where is SARAH MAHIPALA, FNP-C located? ▼
What is SARAH MAHIPALA, FNP-C's NPI number? ▼
Does SARAH MAHIPALA, FNP-C prescribe more brand-name or generic drugs? ▼
How many Nurse Practitioner providers are there in the US? ▼
What drugs does SARAH MAHIPALA, FNP-C prescribe most often? ▼
Does SARAH MAHIPALA, FNP-C accept Medicare? ▼
How can I verify SARAH MAHIPALA, FNP-C's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology